Clinical Trials Browser

OTHER × Prostatic Hyperplasia × Celecoxib × Clear all

NCT01678313 2014-07-15

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Phase 2 Completed

140 enrolled 10 charts

Prostatic Hyperplasia, Lower Urinary Tract Symptoms